These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sickle cell disease at the dawn of the molecular era. Abboud MR; Musallam KM Hemoglobin; 2009; 33 Suppl 1():S93-S106. PubMed ID: 20001639 [TBL] [Abstract][Full Text] [Related]
3. Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I. Kato GJ Hematology Am Soc Hematol Educ Program; 2008; ():186-92. PubMed ID: 19074079 [TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Kato GJ; McGowan V; Machado RF; Little JA; Taylor J; Morris CR; Nichols JS; Wang X; Poljakovic M; Morris SM; Gladwin MT Blood; 2006 Mar; 107(6):2279-85. PubMed ID: 16291595 [TBL] [Abstract][Full Text] [Related]
5. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Kato GJ; Hebbel RP; Steinberg MH; Gladwin MT Am J Hematol; 2009 Sep; 84(9):618-25. PubMed ID: 19610078 [TBL] [Abstract][Full Text] [Related]
6. Intravascular hemolysis and the pathophysiology of sickle cell disease. Kato GJ; Steinberg MH; Gladwin MT J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Morris CR Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078 [TBL] [Abstract][Full Text] [Related]
8. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223 [TBL] [Abstract][Full Text] [Related]
9. Vasculopathy and pulmonary hypertension in sickle cell disease. Potoka KP; Gladwin MT Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L314-24. PubMed ID: 25398989 [TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment. Pavan AR; Terroni B; Dos Santos JL Nitric Oxide; 2024 Aug; 149():7-17. PubMed ID: 38806107 [TBL] [Abstract][Full Text] [Related]
12. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Kato GJ; Gladwin MT; Steinberg MH Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951 [TBL] [Abstract][Full Text] [Related]